BOULDER, Colo., June 13, 2025 /PRNewswire/ — Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that it has commenced an underwritten…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
TULSA, Okla.–(BUSINESS WIRE)–Four startups headquartered in Colorado, Florida and Texas have been selected as winners of the 2026 Rose Rock Bridge Showcase. Austere Environmental, BiaTech, BigMachine AI and Intellicess will receive a share of $400,000 […]
WASHINGTON — Colorado is pioneering a new way for states to crack down on prescription drug costs. In a first-in-the-nation move, a state board voted to create a payment limit for a widely prescribed Amgen […]
Because early detection offers the best chance of surviving cancer, screening tests that involve one quick blood draw are generating excitement. If approved, rather than scheduling downtime and facing intimidating procedures, patients could undergo screening […]
Copyright © 2026 Biotech Networks
